Modern, intuitive, and reliable thermal cyclers excel at optimizing sequencing, cloning, and genotyping throughput. Choosing the right thermal cycler can be a daunting task. Among the considerations ...

Designed with a scalable architecture, the QuantStudio™ 3D Digital PCR System's first generation chips enable up to 20,000 data points in a single run — coverage that satisfies the needs for most ...

Stilla Technologies, a leader in multiplex digital PCR technology, proudly announces the addition of two new digital PCR system configurations to the Nio™ product line, which debuted in November 2023 ...

CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or distribution SALT LAKE CITY, Feb. 5, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. ...

The global molecular diagnostics market is projected to reach $31.8 billion by 2026, up from $17.8 billion in 2021, with the polymerase chain reaction (PCR) segment accounting for the largest share, ...

The polymerase chain reaction (PCR), invented about three decades ago, soon entered mainstream use thanks to an ongoing series of refinements. One particularly important refinement, introduced about ...

When Pieter van Rooyen sold Edico Genome to Illumina four years ago for $100 million, it was an early example of San Diego’s semiconductor and software expertise spilling over into the region’s ...

The Pharos V8 is a laser PCR (polymerase chain reaction) instrument powered by pulse-controlled amplification (PCA) technology. It features ultrafast nucleic acid amplification and microcyclers that ...

Careful strategizing helps make PCR sensitive enough for the most challenging experiments. You have full access to this article via your institution. Scientists are rarely starved for choice when ...

PARIS & CAMBERLEY, England--(BUSINESS WIRE)--Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the acquisition of the entire ...

CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or distribution Mohal Sarabhai, CEO of CoSara, remarked, "We believe this landmark ...

Mohal Sarabhai, CEO of CoSara, remarked, "We believe this landmark regulatory achievement validates the integrity of our quality management system, and that receiving this license for the PCR Pro will ...